Comparing Symbicort vs Trelegy Ellipta
| Symbicort (budesonide / formoterol) | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) |
|
|---|
| Symbicort (budesonide / formoterol) | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Symbicort is used to treat asthma in adults and children 6 years of age and older, and for the maintenance treatment of airflow obstruction and to reduce exacerbations in COPD. It is a combination... View more |
Prescription only
Trelegy Ellipta is approved for the once-daily treatment of adults with chronic obstructive pulmonary disease (COPD) or for adults with asthma. Trelegy Ellipta is an option for the treatment of... View more |
Related suggestions |
|||||||||||||||
| More about Symbicort (budesonide / formoterol) | More about Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Symbicort has an average rating of 6.6 out of 10 from a total of 228 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 26% reported a negative effect. |
Trelegy Ellipta has an average rating of 6.8 out of 10 from a total of 262 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Symbicort side effects |
View all Trelegy Ellipta side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Symbicort prices |
View all Trelegy Ellipta prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other budesonide / formoterol brands include: Breyna |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
7.9 hours |
24 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 859 drugs are known to interact with Symbicort:
|
A total of 543 drugs are known to interact with Trelegy Ellipta:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
July 21, 2006 |
September 18, 2017 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.